CKM and intrahepatic cholangiocarcinoma: cPKM showed evident resistance to RNase R treatment (Figure 1I), and in ICC cells treated with the transcription inhibitor actinomycin D, cPKM was found to be more stable than its corresponding linear transcript (Figure 1J).